Status:
UNKNOWN
Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients
Lead Sponsor:
Gaziosmanpasa Research and Education Hospital
Conditions:
Coronavirus Infection
Eligibility:
All Genders
18-70 years
Brief Summary
Morbidity, mortality and progress depends on systemic inflammation especially in ARDS patients. Previous studies claims that the proportion of mean platellet volume to platellet which can simply be de...
Detailed Description
Covid-19 pneumonia is a spesific disease dispate its similarity to ARDS. There are nomorous of studies that MPV/PLT ratio can predict the mortality, morbidity and the progress of ARDS. Depending on th...
Eligibility Criteria
Inclusion
- Patients over 18 years old who hospitalized with diagnosis of Covid-19 pneumonia between march and may 2020
Exclusion
- Under 18 years old patients
- Patients with heamolytic diaseses
Key Trial Info
Start Date :
June 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 20 2020
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT04408378
Start Date
June 5 2020
End Date
August 20 2020
Last Update
May 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaziosmanpaşa TREH
Istanbul, Gaziosmanpaşa, Turkey (Türkiye), 34255